Vivace Therapeutics

company

About

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$25M
Industries
Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway. At Vivace Therapeutics, they pursue their work with passion, driven by a conviction to help people fight cancer and live life to the fullest.

Based in the San Francisco Bay Area, Vivace Therapeutics is an oncology-focused portfolio-based drug discovery and development company adopting a capital-efficient and modality-indifferent approach to bring novel therapies to patients in need. Their experienced management team and world-class scientists work to advance promising drugs and therapeutic technologies that they believe can help conquer cancer.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$25M
Vivace Therapeutics has raised a total of $25M in funding over 2 rounds. Their latest funding was raised on Jun 28, 2017 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 28, 2017 Series B $25M 1 Sequoia Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Vivace Therapeutics is funded by 1 investors. Sequoia Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Sequoia Capital Yes Series B